Shares of Leidos Holdings shifted dramatically after the defense contractor announced a U.S. Army contract extension worth up to $127 million to keep flying its high-altitude surveillance aircraft over Europe — but a staggering 40.9% after-hours spike to $173.86 has left analysts scrambling to explain a move that far outpaces the deal's size.
A Steady Paycheck, Not a Windfall
The award extends operations for the company's airborne spy-plane system within the U.S. European Command area through summer 2027, with two additional option years.
Leidos has supported this mission since 2020. But at $127 million, this is a continuation contract — not a competitive new win — for a company that now projects fiscal 2026 revenue of $18.2 billion to $18.4 billion. The deal represents roughly 0.7% of full-year sales. No single contract this small normally moves a $15.5 billion market-cap stock by double digits.
A Torrent of Recent Wins Adds Up The ARTEMIS extension lands amid a remarkable contract streak. In recent weeks alone, Leidos secured an $875 million Navy contract, an $85 million Air Force award, and a $926 million corrected Navy deal. In April, the Army awarded an $869 million five-year contract for AI-driven battlefield decision systems.
Total backlog ended last quarter at $48.7 billion, with funded backlog — work the government has already set money aside to pay for — surging 44% year over year. Collectively, these wins reinforce that Leidos is converting pipeline into revenue at an accelerating pace.
The Price Move Doesn't Add Up — Yet Before today's spike, LDOS traded at a price-to-earnings ratio of just 12.0, well below its Professional Services industry median of 23.8.
The stock's 52-week range runs from $98.86 to $205.77 , and the after-hours price of $173.86 vaults it back toward the upper half of that band. One valuation model pegged intrinsic value at $171.71 before the jump , suggesting the stock may have simply snapped toward fair value. Still, a 41% intraday move on a continuation contract strongly implies additional undisclosed catalysts — possibly a larger classified award, M&A rumors, or a data anomaly.
The Bottom Line for Shareholders
Insiders have been net sellers, disposing of $1.5 million more stock than they bought over the past 12 months — hardly a vote of confidence ahead of a breakout. Until Leidos or the market clarifies what else is driving the surge, investors should treat the 41% move with extreme caution: the contract is real, the price action may not be.